Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis

Isoniazid and rifampin are essential components of first-line antituberculosis (anti-TB) therapy. Understanding the relationship between genetic factors and the pharmacokinetics of these drugs could be useful in optimizing treatment outcomes, but this is understudied in children. We investigated the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Dompreh, Albert, Tang, Xiaoli, Zhou, Jianlin, Yang, Hongmei, Topletz, Ariel, Adu Ahwireng, Eugene, Antwi, Sampson, Enimil, Antony, Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Kwara, Awewura
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2018
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826147/
https://ncbi.nlm.nih.gov/pubmed/29263072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02099-17
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares